You stated in that article, each clinical lab will be responsible for obtaining approval from the regulatory agencies in its country.

Could you answer the following four questions:

1.) How much would the approval process cost a lab in the three largest markets you are currently pursuing.

2.) How long does it usually take for approval once the necessary paperwork has been submitted to the approval agency by the lab

3.) Why would the labs in those countries be willing to take on the burden of funding the approval process.

4.) Won't the Elisa Recaf blood test compete directly with the automated test being developed by Inverness and Abbott making Recaf less attractive to those two companies.